Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,112 | 80,386 | 61,661 | 46,600 | 202,989 |
| Marketable Securities | 235,547 | 79,666 | 249,127 | 299,904 | 318,363 |
| Receivables | 56,532 | 5,924 | 4,825 | 7,492 | 911 |
| Inventories | 4,243 | 4,680 | 1,948 | N/A | N/A |
| TOTAL | $337,754 | $173,324 | $321,995 | $357,874 | $532,400 |
| Non-Current Assets | |||||
| PPE Net | 14,047 | 15,865 | 17,687 | 19,390 | 21,227 |
| Intangibles | 64,259 | 94,662 | 96,428 | 97,900 | 97,900 |
| Other Non-Current Assets | 1,655 | 285 | 429 | 461 | 433 |
| TOTAL | $79,961 | $110,812 | $114,544 | $117,751 | $119,560 |
| Total Assets | $417,715 | $284,136 | $436,539 | $475,625 | $651,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,012 | 1,115 | 14,094 | 16,280 | 1,976 |
| Accounts payable and accrued liabilities | 12,178 | 12,052 | 38,762 | 52,877 | 19,725 |
| Accrued Expenses | 42,151 | 21,245 | 12,282 | 32,114 | 24,757 |
| TOTAL | $65,341 | $36,751 | $105,489 | $164,643 | $122,957 |
| Non-Current Liabilities | |||||
| Long Term Debt | 234,171 | 243,887 | 231,576 | 85,167 | 100,960 |
| Deferred Revenues | N/A | 2,339 | 40,351 | 63,372 | 76,499 |
| Other Non-Current Liabilities | 1,102 | 238 | 292 | 805 | 14,367 |
| TOTAL | $235,273 | $273,790 | $262,785 | $153,581 | $243,153 |
| Total Liabilities | $300,614 | $310,541 | $368,274 | $318,224 | $366,110 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,970 | 106,272 | 105,592 | 104,320 | 103,770 |
| Common Shares | 106 | 106 | 106 | 105 | 104 |
| Retained earnings | -1,341,444 | -1,471,577 | -1,365,241 | -1,250,363 | -1,108,934 |
| Other shareholders' equity | 267 | 112 | -126 | -563 | 34 |
| TOTAL | $117,101 | $-26,405 | $68,265 | $157,401 | $285,850 |
| Total Liabilities And Equity | $417,715 | $284,136 | $436,539 | $475,625 | $651,960 |